During the past decade, Hope Women's Cancer Centers-Asheville conducted 21 clinical trials. In the 10-year time frame, 21 clinical trials started and 44 clinical trials were completed, i.e. on average, 209.5% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 18 clinical trials were completed. i.e. 900% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hope Women's Cancer Centers-Asheville" #1 sponsor was "National Cancer Institute (NCI)" with 24 trials, followed by "Gynecologic Oncology Group" with 8 trials sponsored, "SWOG Cancer Research Network" with 7 trials sponsored, "NSABP Foundation Inc" with 6 trials sponsored and "Alliance for Clinical Trials in Oncology" with 6 trials sponsored. Other sponsors include 23 different institutions and companies that sponsored additional 24 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hope Women's Cancer Centers-Asheville" #1 collaborator was "National Cancer Institute (NCI)" with 34 trials as a collaborator, "NRG Oncology" with 12 trials as a collaborator, "SWOG Cancer Research Network" with 5 trials as a collaborator, "NCIC Clinical Trials Group" with 4 trials as a collaborator and "North Central Cancer Treatment Group" with 4 trials as a collaborator. Other collaborators include 29 different institutions and companies that were collaborators in the rest 30 trials.

According to Clinical.Site data, the most researched conditions in "Hope Women's Cancer Centers-Asheville" are "Breast Cancer" (19 trials), "Fallopian Tube Endometrioid Adenocarcinoma" (5 trials), "Fallopian Tube Mucinous Adenocarcinoma" (5 trials), "Fallopian Tube Transitional Cell Carcinoma" (5 trials) and "Ovarian Endometrioid Adenocarcinoma" (5 trials). Many other conditions were trialed in "Hope Women's Cancer Centers-Asheville" in a lesser frequency.

Most popular intervention types in "Hope Women's Cancer Centers-Asheville" are "Drug" (66 trials), "Other" (36 trials), "Biological" (23 trials), "Procedure" (15 trials) and "Radiation" (15 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (23 trials), "Quality-of-Life Assessment" (20 trials), "Paclitaxel" (15 trials), "Carboplatin" (9 trials) and "Placebo" (9 trials). Other intervention names were less common.

The vast majority of trials in "Hope Women's Cancer Centers-Asheville" are 52 trials for "Female" genders and 25 trials for "All" genders.

Currently, there are NaN active trials in "Hope Women's Cancer Centers-Asheville". undefined are not yet recruiting, 5 are recruiting, 28 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 37 completed trials in Hope Women's Cancer Centers-Asheville, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Hope Women's Cancer Centers-Asheville, 1 "Phase 1" clinical trials were conducted, 19 "Phase 2" clinical trials and 55 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".